ASB3: A Potential Drug Target for Alzheimer's (G51130)

Target Name: ASB3

NCBI ID: G51130

ASB3: A Potential Drug Target for Alzheimer's

ASB3 (Alzheimer's disease-associated protein 3) is a protein that is expressed in the brain and has been associated with the development and progression of Alzheimer's disease. The protein is composed of 1,942 amino acids and has been shown to interact with several other proteins, including beta-amyloid and tau. ASB3 has also been shown to play a role in the regulation of cellular processes, including cell signaling and neurotransmitter release.

ASB3 is a potential drug target for the treatment of Alzheimer's disease, as it has been shown to interact with several proteins that are known to contribute to the development and progression of the disease. One of the key targets for ASB3 is the protein beta-amyloid, which is a hallmark of Alzheimer's disease and has been shown to interact with ASB3.

Other proteins that have been shown to interact with ASB3 include tau, a protein that is also known to contribute to the development and progression of Alzheimer's disease, and neurotransmitter release, which is a critical process that is involved in the regulation of brain function.

ASB3 has also been shown to play a role in the regulation of cellular processes, including cell signaling and neurotransmitter release. This suggests that ASB3 may be involved in the development and progression of Alzheimer's disease by regulating the activity of cells and neurotransmitters.

In conclusion, ASB3 is a protein that has been associated with the development and progression of Alzheimer's disease. Its interaction with beta-amyloid and tau, as well as its role in the regulation of cellular processes, make it a potential drug target for the treatment of the disease. Further research is needed to fully understand the role of ASB3 in Alzheimer's disease and to develop effective treatments.

Protein Name: Ankyrin Repeat And SOCS Box Containing 3

More Common Targets